Form 4: enGene Holdings Inc. Director Paul J Hastings Acquires Stock Options
SEC Filing Form 4
Director Paul J Hastings acquired stock options for 40,000 common shares of enGene Holdings Inc. on June 15, 2024.
Summary
- Paul J Hastings, a director of enGene Holdings Inc., filed a Form 4 on June 18, 2024.
- The filing reports a transaction that occurred on June 15, 2024.
- Hastings acquired stock options for 40,000 common shares at an exercise price of $9.
- The options vest in three equal installments on the first, second, and third anniversaries of May 15, 2024, and expire on June 15, 2034.
- Following the transaction, Hastings directly owns options for 40,000 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports a standard transaction. The acquisition of stock options by a director is generally viewed as a slightly positive sign, but it's a routine event.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| May 15, 2024 | Date vesting commenced for the stock options. |
| June 15, 2024 | Date of the transaction where stock options were acquired. |
| June 15, 2034 | Expiration date of the stock options. |
| June 18, 2024 | Date the Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.